» Articles » PMID: 35069196

Anticancer Applications and Pharmacological Properties of Piperidine and Piperine: A Comprehensive Review on Molecular Mechanisms and Therapeutic Perspectives

Overview
Journal Front Pharmacol
Date 2022 Jan 24
PMID 35069196
Authors
Affiliations
Soon will be listed here.
Abstract

Piperine and piperidine are the two major alkaloids extracted from black pepper (); piperidine is a heterocyclic moiety that has the molecular formula (CH)NH. Over the years, many therapeutic properties including anticancer potential of these two compounds have been observed. Piperine has therapeutic potential against cancers such as breast cancer, ovarian cancer, gastric cancer, gliomal cancer, lung cancer, oral squamous, chronic pancreatitis, prostate cancer, rectal cancer, cervical cancer, and leukemia. Whereas, piperidine acts as a potential clinical agent against cancers, such as breast cancer, prostate cancer, colon cancer, lung cancer, and ovarian cancer, when treated alone or in combination with some novel drugs. Several crucial signalling pathways essential for the establishment of cancers such as STAT-3, NF-κB, PI3k/Aκt, JNK/p38-MAPK, TGF-ß/SMAD, Smac/DIABLO, p-IκB etc., are regulated by these two phytochemicals. Both of these phytochemicals lead to inhibition of cell migration and help in cell cycle arrest to inhibit survivability of cancer cells. The current review highlights the pharmaceutical relevance of both piperine and piperidine against different types of cancers.

Citing Articles

Integrative analysis of mitochondrial and immune pathways in diabetic kidney disease: identification of AASS and CASP3 as key predictors and therapeutic targets.

Yu X, Hu Y, Jiang W Ren Fail. 2025; 47(1):2465811.

PMID: 39988817 PMC: 11852243. DOI: 10.1080/0886022X.2025.2465811.


Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers.

Sravani A, Thomas J Heliyon. 2025; 11(3):e41964.

PMID: 39959483 PMC: 11830326. DOI: 10.1016/j.heliyon.2025.e41964.


Harnessing the anticancer potential of Piper nigrum: a synergistic approach to chemotherapy enhancement and reduced side effects.

Wiraswati H, Maruf I, Hidayati N, Ramadhanti J, Calina D, Sharifi-Rad J Discov Oncol. 2025; 16(1):10.

PMID: 39760812 PMC: 11704108. DOI: 10.1007/s12672-024-01716-4.


Exploring Piperine: Unleashing the multifaceted potential of a phytochemical in cancer therapy.

Tripathi D, Gupta T, Pandey P Mol Biol Rep. 2024; 51(1):1050.

PMID: 39395120 DOI: 10.1007/s11033-024-09978-5.


Piperine Enhances the Anticancer Effects of Cisplatin on Tongue Squamous Cell Carcinoma Cell Line by Inducing Cell Apoptosis.

Mohamed M, Elgayar S, Abd Elaziz E Asian Pac J Cancer Prev. 2024; 25(9):3219-3228.

PMID: 39342601 PMC: 11700342. DOI: 10.31557/APJCP.2024.25.9.3219.


References
1.
Friedman H, Kerby T, Calvert H . Temozolomide and treatment of malignant glioma. Clin Cancer Res. 2000; 6(7):2585-97. View

2.
Fyhrquist P, Virjamo V, Hiltunen E, Julkunen-Tiitto R . Epidihydropinidine, the main piperidine alkaloid compound of Norway spruce (Picea abies) shows promising antibacterial and anti-Candida activity. Fitoterapia. 2017; 117:138-146. DOI: 10.1016/j.fitote.2017.01.011. View

3.
Lukaszewicz-Zajac M, Mroczko B, Szmitkowski M . [The role of interleukin-6 and C-reactive protein in gastric cancer]. Pol Merkur Lekarski. 2011; 29(174):382-6. View

4.
Liu H, Zhou M . Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways. BMC Complement Altern Med. 2017; 17(1):531. PMC: 5729262. DOI: 10.1186/s12906-017-2023-6. View

5.
Chai J, Du C, Wu J, Kyin S, Wang X, Shi Y . Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature. 2000; 406(6798):855-62. DOI: 10.1038/35022514. View